Director/PDMR Shareholding
RNS Announcements
2024
Result of AGM
26 July 2023
ProBiotix Health plc (AQSE: PBX), a life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions, announces that at the AGM held earlier today, all resolutions were duly passed.
The full voting results will be available on the website in due course here: https://probiotixhealth-ir.com/
For further information, please contact:
ProBiotix Health plc | https://probiotixhealth-ir.com/ |
Steen Andersen, Chief Executive | Contact via Walbrook below |
Peterhouse Capital Ltd (AQSE Corporate Adviser and Broker) | Tel: 020 7469 0930 |
Mark Anwyl | |
Duncan Vasey | |
Walbrook PR Ltd | [email protected] |
Anna Dunphy | Mob: 07876 741 001 |
2023
Result of AGM
26 July 2023
ProBiotix Health plc (AQSE: PBX), a life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions, announces that at the AGM held earlier today, all resolutions were duly passed.
The full voting results will be available on the website in due course here: https://probiotixhealth-ir.com/
For further information, please contact:
ProBiotix Health plc | https://probiotixhealth-ir.com/ |
Steen Andersen, Chief Executive | Contact via Walbrook below |
Peterhouse Capital Ltd (AQSE Corporate Adviser and Broker) | Tel: 020 7469 0930 |
Mark Anwyl | |
Duncan Vasey | |
Walbrook PR Ltd | [email protected] |
Anna Dunphy | Mob: 07876 741 001 |
2022
Result of AGM
26 July 2023
ProBiotix Health plc (AQSE: PBX), a life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions, announces that at the AGM held earlier today, all resolutions were duly passed.
The full voting results will be available on the website in due course here: https://probiotixhealth-ir.com/
For further information, please contact:
ProBiotix Health plc | https://probiotixhealth-ir.com/ |
Steen Andersen, Chief Executive | Contact via Walbrook below |
Peterhouse Capital Ltd (AQSE Corporate Adviser and Broker) | Tel: 020 7469 0930 |
Mark Anwyl | |
Duncan Vasey | |
Walbrook PR Ltd | [email protected] |
Anna Dunphy | Mob: 07876 741 001 |
Latest RNS News
Latest Interview
Aquis-listed ProBiotix Health taps into demand for cardiovascular disease treatments
Stephen O'Hara | 23 February 2023
IG UK | Youtube